Rapid detection of extended-spectrum β-lactamase-producing bacteria using DPS192iX
-
- KOBAYASHI Saori
- Department of Clinical Laboratory, Kobe University Hospital
-
- NAKAMURA Tatsuya
- Department of Clinical Laboratory, Kobe University Hospital
-
- KUSUKI Mari
- Department of Clinical Laboratory, Kobe University Hospital
-
- OHNUMA Kenichiro
- Department of Clinical Laboratory, Kobe University Hospital
-
- HAYASHI Nobuhide
- Department of Clinical Laboratory, Kobe University Hospital
-
- OHJI Goh
- Division of Infection Diseases Therapeutics, Kobe University Hospital
-
- SAEGUSA Jun
- Department of Clinical Laboratory, Kobe University Hospital
Bibliographic Information
- Other Title
-
- DPS192iXを使用したExtended Spectrum β-lactamase産生菌の迅速検出に関する検討
Search this article
Description
<p>Drug-resistant gram-negative bacilli have recently emerged as a major problem worldwide. The production of extended-spectrum β-lactamases (ESBLs) is an important resistance mechanism of pathogenic bacteria, which impedes the treatment of infections caused by gram-negative bacilli with drugs. Therefore, there is a compelling need to develop rapid detection methods for ESBL-producing bacteria. Herein, we evaluated the performance of a drug-susceptibility measurement instrument, DPS192iX (Eiken Chemical Co., Ltd.) for the rapid detection of ESBL-producing bacteria using various β-lactamase-producing Enterobacteriaceae strains. Seventy-one β-lactamase-producing strains were used for the analysis. The concordance between detection rates (within +/−1 difference in each tube) was >94% for all test agents compared with those obtained by the conventional method. The detection rates of 28 ESBL-producing strains were high: 96% for CTX, 68% for CAZ, 93% for CPR, and 96% for CPDX at 18 hours and 75% for CTX and 96% for CPDX at 5 hours. At 18 hours, all the ESBL-producing strains were detected using at least one of the agents. The results obtained should, however, be carefully examined because they depend on the genotypes of the ESBL-producing strains. Nevertheless, the drug susceptibilities of various β-lactamase-producing Enterobacteriaceae strains can be determined with high accuracy by using DPS192iX in routine tests. In addition, the ESBL-producing strains can be rapidly detected by using DPS192iX. In conclusion, the findings of this study demonstrate that the use of DPS192iX could ensure the proper use of antibiotics and thus contribute to the development of control measures against hospital infections caused by drug-resistant bacteria.</p>
Journal
-
- Japanese Journal of Medical Technology
-
Japanese Journal of Medical Technology 66 (6), 649-655, 2017
Japanese Association of Medical Technologists
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205741589248
-
- NII Article ID
- 130006234087
-
- ISSN
- 21885346
- 09158669
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed